20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
On December 13, 2019, a split Eleventh Circuit Court of Appeals (sitting en banc) ruled that several...
Read More >
In this episode of the FCPA Compliance Report, I visit Kelly Leonard, Executive Director, Insights a...
Read More >
With the start of a new year—and a new decade—employers in San Francisco, California, Waterloo, Io...
Read More >
The Department of Justice Antitrust Division is intensifying its focus on the financial services sec...
Read More >
Portal, Ga., Store Manager Refused to Interview Applicant After Seeing Her Arm in a Sling, Federal A...
Read More >
Late on Friday, December 20, 2019, President Trump signed into law government funding legislation fo...
Read More >